Literature DB >> 20554026

Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome.

Geir Helgeland1, Axel Petzold, Jana Midelfart Hoff, Nils Erik Gilhus, Gordon T Plant, Fredrik Robert Romi.   

Abstract

Myasthenia gravis (MG) is an autoimmune disorder where patients develop autoantibodies towards skeletal muscle proteins (e.g. acetylcholine receptor and muscle specific kinase), causing weakness in striated muscles. Ocular MG (OMG) represents a subtype of (MG) affecting only the periocular muscles. The pathogenesis of this phenotype remains unclear. Heat Shock Protein 70 (Hsp70) plays a role in immune regulation. Antibodies against this protein are associated with several autoimmune diseases, and its biological significance has been shown in vivo. We have therefore examined the concentration of anti-Hsp70 antibodies in sera from 35 OMG patients and 94 patients with generalized MG (GMG) using ELISA assays. The antibody concentrations were compared to those in patients with multiple sclerosis (MS), Guillain-Barré syndrome (GBS) and to healthy controls. MG patients had significantly higher anti-Hsp70 antibody concentrations than both MS patients and healthy controls. GBS patients had higher antibody levels than all other groups. No difference in antibody levels was found when comparing OMG and GMG. Our results suggest that patients with MG and GBS have a previous or current increased exposure to Hsp70 antigens. The similarity between GMG and OMG strengthens the hypothesis that OMG represents a systemic disease, similar to GMG. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554026     DOI: 10.1016/j.jneuroim.2010.04.024

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis.

Authors:  Fredrik Romi; Shigeaki Suzuki; Norihiro Suzuki; Axel Petzold; Gordon T Plant; Nils Erik Gilhus
Journal:  J Neurol       Date:  2011-12-14       Impact factor: 4.849

2.  Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.

Authors:  Jiayin Lu; Jing Li; Tai-qing Zhu; Longbo Zhang; Yuzhong Wang; Fa-fa Tian; Huan Yang
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

3.  Myasthenia gravis presenting like guillain-barré syndrome.

Authors:  Isha Misra; Frehiwot D Temesgen; Noha Soleiman; Janaki Kalyanam; Mohankumar Kurukumbi
Journal:  Case Rep Neurol       Date:  2012-09-12

4.  High prevalence of Campylobacter jejuni CC21 and CC257 clonal complexes in children with gastroenteritis in Tehran, Iran.

Authors:  Mahnaz Sarhangi; Bita Bakhshi; Shahin Najar Peeraeyeh
Journal:  BMC Infect Dis       Date:  2021-01-23       Impact factor: 3.090

Review 5.  Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.

Authors:  Luis Querol; Cinta Lleixà
Journal:  Neurotherapeutics       Date:  2021-09-21       Impact factor: 7.620

Review 6.  Impact of Heat Shock Proteins in Neurodegeneration: Possible Therapeutical Targets.

Authors:  Giangiacomo Beretta; Aida Loshaj Shala
Journal:  Ann Neurosci       Date:  2022-01-31

Review 7.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

8.  HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications.

Authors:  S Janik; A I Schiefer; C Bekos; P Hacker; T Haider; J Moser; W Klepetko; L Müllauer; H J Ankersmit; B Moser
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

9.  Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis.

Authors:  Jürgen Thanner; Christine Bekos; Cecilia Veraar; Stefan Janik; Maria Laggner; Panja M Boehm; Ana-Iris Schiefer; Leonhard Müllauer; Walter Klepetko; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

10.  Zika E Glycan Loop Region and Guillain-Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development.

Authors:  Grégorie Lebeau; Etienne Frumence; Jonathan Turpin; Floran Begue; Jean-Jacques Hoarau; Gilles Gadea; Pascale Krejbich-Trotot; Philippe Desprès; Wildriss Viranaicken
Journal:  Vaccines (Basel)       Date:  2021-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.